Susann Meyer

27.08.2021

Mov. Disord.

27.08.2021

Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Thom T, Schmitz M, Fischer AL, Correia A, Correia S, Llorens F, Pique AV, Möbius W, Domingues R, Zafar S, Stoops E, Silva CJ, Fischer A, Outeiro TF, Zerr I

27.08.2021

City-Light poster campaign at Wilhelmsplatz, Göttingen
Photo: Fritz Kobe, MBExC, UMG

27.08.2021

The MBExC starts City Light poster campaign

Over the next 12 months, the MBExC will be present at Göttingen, Wilhelmsplatz with a series of six beautifully illustrated and illuminated City Light posters to engage and inspire people […]

24.08.2021

Commun Biol.

24.08.2021

The structure of a dimeric form of SARS-CoV-2 polymerase

Jochheim FA, Tegunov D, Hillen HS, Schmitzova J, Kokic G, Dienemann C, Cramer P

23.08.2021

MBExC X-ray Symposium 2021 at Paulinerkirche, Göttingen
Photo: Fritz Kobe, MBExC, UMG

23.08.2021

MBExC X-ray Symposium in person

The international MBExC Symposium “X-ray based imaging on different scales for biomedical application” took place in person last Monday at Paulinerkirche, Göttingen.

16.08.2021

The antiviral drug candidate molnupiravir (yellow) is incorporated into the viral RNA, where it leads to mutations (purple) that ultimately prevent the virus from replicating.
Florian Kabinger, Christian Dienemann and Patrick Cramer @MPI-BPC

16.08.2021

Molecular mechanisms of corona drug candidate Molnupiravir unraveled

Studies, including work by MBExC member Patrick Cramer at the MPI for Biophysical Chemistry and researchers at JMU Würzburg, showed why the drug molnupiravir has a rather weak effect on the virus.

13.08.2021

Eur J Med Genet

13.08.2021

MFSD2A-associated primary microcephaly – Expanding the clinical and mutational spectrum of this ultra-rare disease

Khuller K, Yigit G, Grijalva CM, Altmüller J, Thiele H, Nürnberg P, Elcioglu NH, Yeter B, Hehr U, Stein A, Della Marina A, Köninger A, Depienne C, Kaiser FJ, Wollnik B, Kuechler A